You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Patent: 10,010,585


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,010,585
Title:Methods of treating vestibular schwannoma and reducing hearing or neurite loss caused by vestibular schwannoma
Abstract: Methods to reduce the proliferation of vestibular schwannoma (VS) cells and/or provide neuroprotection to reduce the risk of sensorineural hearing loss (SNHL), vestibular dysfunction and facial nerve paralysis in subjects with VS. The methods can include one or more of decreasing TNF-.alpha. activity or expression; decreasing NF-.kappa.B expression or activity; decreasing COX-2 expression or activity; administering FGF2; decreasing HGF expression or activity; or decreasing c-Met expression or activity.
Inventor(s): Stankovic; Konstantina (Boston, MA), Dilwali; Sonam (Dallas, TX)
Assignee: Massachusetts Eye and Ear Infirmary (Boston, MA)
Application Number:14/741,332
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,010,585

Introduction

When delving into the world of patents, particularly those granted by the United States Patent and Trademark Office (USPTO), understanding the claims and the broader patent landscape is crucial. This analysis will focus on United States Patent 10,010,585, though the specific details of this patent are not provided in the sources, we will use general principles and strategies to analyze its claims and context.

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of protection for an invention. They must be carefully crafted to balance breadth and precision[4].

The Strategic Role of Claim Composition

The composition of patent claims directly influences a patent’s strength, enforceability, and commercial potential. Well-crafted claims can provide broad protection, deterring infringement and offering a competitive edge. Conversely, poorly structured claims may leave vulnerabilities that competitors can exploit, diminishing the patent’s value[4].

Crafting Effective Claims

Balancing Act: Breadth vs. Precision

Effective claim drafting involves balancing the breadth of protection with the precision needed to differentiate the invention from prior art. Claims should be broad enough to cover various embodiments of the invention but specific enough to avoid ambiguity and ensure they are defensible[4].

Claim Differentiation: Independent and Dependent Claims

Utilizing both independent and dependent claims is a key strategy. Independent claims broadly cover the core innovation, while dependent claims delve into specifics, offering layered protection around the core idea. For example, in a tech invention like a new smartphone technology, independent claims might cover the unique method of interaction, while dependent claims could specify gestures or voice commands[4].

Adapting Claims to Meet USPTO Requirements

Responding to Examination Feedback

During the patent prosecution process, claims must be adapted to meet USPTO requirements. This includes responding effectively to examination feedback, such as addressing issues of non-obviousness and novelty. Tailoring claims to preemptively address these concerns can streamline the prosecution process[4].

Maximizing the Use of Claim Quotas

The USPTO allows a certain number of claims without additional fees. Strategic claim management involves utilizing this allowance to its fullest potential, ensuring the patent covers as many aspects of the invention as possible without exceeding cost thresholds. This includes consolidating claims and introducing new dependent claims to highlight different embodiments or aspects of the invention[4].

The Importance of Claim Clarity and Precision

Avoiding Ambiguity

Clarity and precision in claim drafting are paramount. Ambiguous or overly broad claims can lead to challenges during the patent examination process and may weaken the patent’s enforceability. Claims must be meticulously written to describe the invention accurately and clearly, ensuring they can withstand legal scrutiny and protect the invention against infringement[4].

Beyond Drafting: Claim Management for Portfolio Development

Monitoring and Adjusting Claims Post-Grant

Effective claim management extends beyond the initial drafting and prosecution phases. As technologies evolve and markets shift, maintaining the relevance and enforceability of patent claims is essential. This involves monitoring the patent landscape, adapting to changes, and making necessary adjustments to the claims to ensure they remain defensible and aligned with business objectives[4].

The Broader Patent Landscape

Trends in Patent Applications

The number of patent applications and the number of claims filed with each application are increasing. This trend is partly due to legal precedents, such as the case of Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co. Ltd., which interpreted that narrowing amendments to claims elements can significantly limit patent claims scope[2].

Automated Systems for Patent Claim Management

Given the complexity and volume of patent claims, automated systems and methods have been developed to facilitate patent grant and patent application claims examination. These systems can import, parse, and generate hierarchical claims diagrams, making it easier for users to review and manage patent claims[2].

Case Study: Hypothetical Analysis of United States Patent 10,010,585

While specific details of United States Patent 10,010,585 are not available, here is a hypothetical analysis based on general principles:

  • Claim Structure: The patent likely includes a mix of independent and dependent claims to ensure broad protection while differentiating the invention from prior art.
  • Precision and Clarity: Each claim would be meticulously written to avoid ambiguity and ensure clarity, making them defensible against legal challenges.
  • USPTO Compliance: The claims would be adapted to meet USPTO requirements, including responding to examination feedback and maximizing the use of claim quotas.
  • Post-Grant Management: The patent holder would need to monitor the patent landscape and adjust claims as necessary to maintain their relevance and enforceability.

Key Takeaways

  • Balanced Claim Drafting: Claims must balance breadth and precision to provide robust protection.
  • Clarity and Precision: Avoid ambiguity to ensure claims are defensible and enforceable.
  • Adaptation to USPTO Requirements: Respond effectively to examination feedback and maximize claim quotas.
  • Post-Grant Management: Continuously monitor and adjust claims to maintain their relevance and enforceability.
  • Automated Systems: Utilize automated systems to streamline the management of patent claims.

FAQs

Q: What is the importance of clarity in patent claims? A: Clarity in patent claims is crucial to avoid ambiguity, which can lead to challenges during the patent examination process and weaken the patent’s enforceability.

Q: How do independent and dependent claims work together? A: Independent claims broadly cover the core innovation, while dependent claims delve into specifics, offering layered protection around the core idea.

Q: Why is it important to adapt claims to meet USPTO requirements? A: Adapting claims to meet USPTO requirements streamlines the patent prosecution process and strengthens the remaining claims by making them more defensible against legal challenges.

Q: What role do automated systems play in patent claim management? A: Automated systems facilitate the import, parsing, and generation of hierarchical claims diagrams, making it easier for users to review and manage patent claims.

Q: How should patent holders manage their claims post-grant? A: Patent holders should continuously monitor the patent landscape and adjust claims as necessary to maintain their relevance and enforceability.

Sources

  1. US20150359851A1 - Methods of treating vestibular schwannoma and reducing hearing or neurite loss caused by vestibular schwannoma.
  2. US20110138338A1 - Patent Claims Analysis System and Method.
  3. City of Tacoma Request for Quotation - Not relevant to the topic.
  4. TT Consultants - Strategies for Effective Patent Claim Management.
  5. AU2009239429A1 - Auris formulations for treating otic diseases and conditions.

More… ↓

⤷  Subscribe

Details for Patent 10,010,585

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Janssen Biotech, Inc. REMICADE infliximab For Injection 103772 August 24, 1998 10,010,585 2034-06-16
Immunex Corporation ENBREL etanercept For Injection 103795 November 02, 1998 10,010,585 2034-06-16
Immunex Corporation ENBREL etanercept For Injection 103795 May 27, 1999 10,010,585 2034-06-16
Immunex Corporation ENBREL etanercept Injection 103795 September 27, 2004 10,010,585 2034-06-16
Immunex Corporation ENBREL etanercept Injection 103795 February 01, 2007 10,010,585 2034-06-16
Immunex Corporation ENBREL MINI etanercept Injection 103795 September 14, 2017 10,010,585 2034-06-16
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.